Kim Sablich Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kim Sablich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kim Sablich. Kim Sablich is a EVP & GM, North America in Jazz Pharmaceuticals plc ($JAZZ) and a Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and a Chief Commercial Officer in Myovant Sciences Ltd. ($MYOV).
Address: C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE 94005 CA
Companies in which Kim Sablich is an Insider
Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kim Sablich: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim Sablich: EVP & GM, North America
Holdings: 16,800 shares
Current Value: $2,100,840
Latest Transaction: Aug 07 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim Sablich: Chief Commercial Officer
Holdings: 146,710 shares
Current Value: $1,565,396
Latest Transaction: Apr 07 2020
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kim Sablich
Sentiment: All, EIGR, JAZZ, MYOV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | EIGR | Eiger BioPharmaceu ... | Sablich Kim | Director | Option Exercise | A | 8.43 | 25,000 | 210,750 | 25,000 | |
| Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Option Exercise | A | 127.07 | 38,856 | 4,937,432 | 38,856 | |
| Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Option Exercise | A | 127.07 | 3,144 | 399,508 | 3,144 | |
| Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Grant | A | 0.00 | 16,800 | 0 | 16,800 | 0 to 16.8 K |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Option Exercise | A | 8.08 | 134,464 | 1,086,469 | 134,464 | |
| Apr 07 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Grant | A | 0.00 | 87,805 | 0 | 146,710 | 58.9 K to 146.7 K (+149.06 %) |
| Mar 19 2020 | MYOV | Myovant Sciences L ... | Sablich Kim | Chief Commercial Of ... | Sell | S | 6.93 | 15 | 104 | 58,905 | 58.9 K to 58.9 K (-0.03 %) |